These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7018942)

  • 1. Photochemotherapy of Sézary syndrome.
    Kövary PM; Frosch P; Macher E
    Dermatologica; 1981; 162(2):112-7. PubMed ID: 7018942
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of Sézary syndrome by extracorporeal photochemotherapy].
    Bohmeyer J; Otte HG; Stadler R
    Hautarzt; 1996 Jan; 47(1):24-8. PubMed ID: 8835000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sézary cell counts in treatment of the Sézary syndrome.
    Zackheim HS
    J Am Acad Dermatol; 1991 Oct; 25(4):731-2. PubMed ID: 1791233
    [No Abstract]   [Full Text] [Related]  

  • 4. [The Sézary syndrome].
    Ferreira F; Correia TM; Callabro L; Andrade J
    Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sézary syndrome in an 11-year-old girl.
    Meister L; Duarte AM; Davis J; Perez JL; Schachner LA
    J Am Acad Dermatol; 1993 Jan; 28(1):93-5. PubMed ID: 8425978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with extracorporeal photopheresis, interferon-alpha, PUVA and topical corticosteroids in the management of Sézary syndrome.
    Booken N; Weiss C; Utikal J; Felcht M; Goerdt S; Klemke CD
    J Dtsch Dermatol Ges; 2010 Jun; 8(6):428-38. PubMed ID: 20180887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and established treatment options for mycosis fungoides and Sézary syndrome - an update.
    Dugas-Breit S; Schulze HJ; Hallermann C
    J Dtsch Dermatol Ges; 2014 Jul; 12(7):561-9. PubMed ID: 24889480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma.
    McGinnis KS; Shapiro M; Vittorio CC; Rook AH; Junkins-Hopkins JM
    Arch Dermatol; 2003 Jun; 139(6):771-5. PubMed ID: 12810509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo effects of photodynamic therapy in cutaneous T cell lymphoma.
    Boehncke WH; König K; Rück A; Kaufmann R; Sterry W
    Acta Derm Venereol; 1994 May; 74(3):201-5. PubMed ID: 7915462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sézary syndrome.
    James MP; Warin AP
    Clin Exp Dermatol; 1979 Jun; 4(2):255-61. PubMed ID: 498579
    [No Abstract]   [Full Text] [Related]  

  • 11. Photochemotherapy for mycosis fungoides: long-term followup study.
    Roenigk HH
    Cancer Treat Rep; 1979 Apr; 63(4):669-73. PubMed ID: 445519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy for Sézary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy. Clinical, molecular, and immunologic observations.
    Rook AH; Prystowsky MB; Cassin M; Boufal M; Lessin SR
    Arch Dermatol; 1991 Oct; 127(10):1535-40. PubMed ID: 1929461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extracorporeal photopheresis in the therapy of Sézary syndrome].
    Marschalkó M; Knobler R; Soós G; Berecz M; Pálóczy K; Rácz I
    Orv Hetil; 1993 Jun; 134(23):1253-7. PubMed ID: 8332344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated epidermolytic acanthoma revealed by PUVA.
    Nakagawa T; Nishimoto M; Takaiwa T
    Dermatologica; 1986; 173(3):150-3. PubMed ID: 3770261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sézary syndrome-an unusual case.
    Weinerman BH; Lu LC
    Cancer; 1981 Jun; 47(12):2946-51. PubMed ID: 7260882
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sézary syndrome (author's transl)].
    Konrads A; Laaser U; Mödder B; Hummerich W; Lang R; Meurer KA; Zach J; Steinbrich W; Krueger GR; Schaefer HE
    Dtsch Med Wochenschr; 1980 Mar; 105(11):378-83. PubMed ID: 7363776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leonine facies due to Sezary syndrome: complete clinical, radiologic, and molecular remission with alemtuzumab.
    Kho B; Wong HHN; Sin CF; Leung RYY; Kwong YL
    Ann Hematol; 2017 Dec; 96(12):2121-2123. PubMed ID: 28828693
    [No Abstract]   [Full Text] [Related]  

  • 18. Sézary-type cutaneous T-cell leukaemia. Response to Winkelmann regimen.
    Harland CC; Balsitis M; Millard LG
    Acta Derm Venereol; 1990; 70(3):251-3. PubMed ID: 1972843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New developments in Sézary syndrome].
    Caudron A; Marie-Cardine A; Bensussan A; Bagot M
    Ann Dermatol Venereol; 2012 Jan; 139(1):31-40. PubMed ID: 22225740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-Sézary syndrome.
    Winkelmann RK; Buechner SA; Diaz-Perez JL
    J Am Acad Dermatol; 1984 Jun; 10(6):992-9. PubMed ID: 6234331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.